Bank Mandiri Sets Rp6.16 Trillion Interim Dividend, BMRI to Pay Rp66 a Share

Bank Mandiri shareholders are set to receive another cash distribution after the Indonesian state-controlled lender approved an interim dividend for the 2026 financial year.

The bank, listed on the Indonesia Stock Exchange under ticker BMRI, will distribute approximately Rp6.16 trillion, equivalent to Rp66 for each outstanding share.

The decision received approval from Bank Mandiri's Board of Commissioners for a Board of Directors resolution dated September 3, 2026.

What investors do not yet have is the payment timetable.

Rp66 for Each BMRI Share

Bank Mandiri has 93,333,333,332 shares outstanding.

Applying a Rp66 dividend to that share count produces an aggregate interim distribution of approximately Rp6.16 trillion.

The actual amount received by an individual shareholder will depend on the number of eligible shares held according to the shareholder-recording rules that will be specified in the forthcoming dividend schedule.

The distribution relates specifically to the 2026 financial year and is classified as an interim dividend.

Cum Date and Payment Date Are Still Pending

Bank Mandiri has not yet announced the detailed timetable for the dividend.

As of the September 4 disclosure, investors are still waiting for the cum-dividend date, ex-dividend date, recording date and payment date.

The company said those dates would be disclosed separately in accordance with Indonesia Stock Exchange rules governing interim dividend distributions.

That distinction matters because merely owning BMRI shares today does not automatically determine eligibility.

Investors will need to refer to the official timetable once it is published.

What Does an Interim Dividend Mean?

An interim dividend is a cash distribution made before the completion of a company's full-year dividend process.

For shareholders, it allows part of corporate earnings to be returned before a final annual dividend is determined.

For the company, the decision requires sufficient capital and liquidity to ensure that distributing cash does not compromise the business.

Bank Mandiri said the 2026 interim dividend would not have a material impact on its operations, legal position, financial condition or business continuity.

Foreign Investors Were Buying BMRI

The dividend announcement comes during a period of strong foreign demand for Bank Mandiri shares.

On September 3, foreign investors recorded approximately Rp471.38 billion in net purchases of BMRI.

That made Bank Mandiri the largest foreign net-buy target on the Indonesian equity market during the session.

BMRI shares also gained 2.29% to close at Rp4,460.

Other stocks attracting significant foreign buying included BBCA, CPIN, ANTM and ADRO.

The timing is notable, but it does not prove that foreign investors were buying BMRI because of the dividend.

Institutional flows can reflect many factors, including valuation, earnings expectations, interest-rate forecasts, portfolio rebalancing and broader market conditions.

What Is the Implied Interim Dividend Yield?

Using BMRI's September 3 closing price of Rp4,460 and the announced Rp66 dividend, the interim distribution represents a yield of roughly 1.48%.

That figure requires context.

It is based on one specific share price and will change as BMRI's market price moves.

More importantly, the 1.48% figure relates only to this newly announced interim dividend. It should not be treated as Bank Mandiri's total dividend yield for the full 2026 financial year.

Any future dividend distribution would depend on the company's results and subsequent corporate decisions.

Bank Mandiri Has Used Interim Dividends Before

The latest payout is not Bank Mandiri's first recent interim dividend.

In January 2026, the bank distributed an interim dividend for the 2025 financial year worth Rp100 per share, for a total payment of approximately Rp9.3 trillion.

The previous distribution provides useful historical context but does not establish a fixed dividend pattern.

Dividend amounts can vary depending on profitability, capital requirements, liquidity, growth plans and management decisions.

Investors should therefore avoid assuming future payouts will match previous ones.

Four Dates Investors Should Watch

Once Bank Mandiri publishes the official schedule, four dates will be particularly important.

The cum-dividend date generally marks the final trading point at which a purchase can still carry the relevant dividend entitlement under applicable settlement rules.

The ex-dividend date comes afterward, when newly purchased shares no longer carry that dividend right.

The recording date identifies eligible shareholders in the company's records.

Finally, the payment date determines when the cash distribution is transferred to eligible investors.

None of those dates had been announced for the 2026 interim dividend as of the September 4 disclosure.

Dividend Size Is Only Part of the BMRI Story

For long-term investors, a Rp6.16 trillion dividend may be important, but it is only one component of Bank Mandiri's investment case.

Other variables include loan growth, asset quality, net interest margin, credit costs, capital adequacy, profitability and valuation.

Macroeconomic conditions can also affect Indonesian banks through interest rates, currency movements and credit demand.

A dividend announcement also does not guarantee a higher share price.

Stocks can adjust around the ex-dividend period, while broader market conditions may outweigh the impact of a cash distribution.

The dividend should therefore be evaluated alongside the bank's underlying financial performance.

What Happens Next?

Bank Mandiri has confirmed the amount: Rp66 per share and approximately Rp6.16 trillion in total.

The next piece of information shareholders need is the official distribution timetable.

Until Bank Mandiri publishes that schedule, investors should avoid relying on unofficial cum-date or payment-date estimates circulating elsewhere.

The announcement nevertheless adds another development to an active period for BMRI, following strong foreign buying and a 2.29% share-price gain on September 3.

For shareholders, the focus now turns to both the dividend timetable and the bank's broader financial performance through the remainder of 2026.

Disclaimer: This article is for informational and educational purposes only and does not constitute personalized investment advice or a recommendation to buy, sell or hold BMRI shares.